WS13.3 Tobacco smoke exposure limits the benefit of Symdeko® in paediatric cystic fibrosis patients: Cystic Fibrosis Foundation Patient Registry analysis
Abstract
No abstract.
Paper Details
Title
WS13.3 Tobacco smoke exposure limits the benefit of Symdeko® in paediatric cystic fibrosis patients: Cystic Fibrosis Foundation Patient Registry analysis
Published Date
Jun 1, 2020
Journal
Volume
19
Pages
S22 - S22
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History